Skip to Main Content
Products
Oncology
Prenatal
Technology
Technology
Publications
Careers
Working with us
Open Positions
Company
Mission, Vision, Values
Leadership & Board
Company Milestones
News & Media
Press Releases
Events
Media Coverage
Social Media
Investors
Contact
News & Media
All Resources
All Categories
Media Coverage
Press Releases
General Information
All Years
2025
2024
2023
2022
2021
2020
2019
Filter by Category
Media Coverage
Press Releases
General Information
Filter by Year
2025
2024
2023
2022
2021
2020
2019
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press Releases
Press Releases
December 2, 2022
2022
2022
BillionToOne Appoints Tom Lynch, JD, as General Counsel & Chief Compliance Officer
Learn More
Press Releases
December 2, 2022
2022
2022
BillionToOne Appoints Tom Lynch, JD, as General Counsel & Chief Compliance Officer
Learn More
General Information
General Information
October 31, 2022
2022
2022
CA Superior Court Halts CDPH’s Exclusivity of Trisomy Screening Through the CA PNS Program
Learn More
General Information
October 31, 2022
2022
2022
CA Superior Court Halts CDPH’s Exclusivity of Trisomy Screening Through the CA PNS Program
Learn More
Press Releases
Press Releases
September 30, 2022
2022
2022
BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen
Learn More
Press Releases
September 30, 2022
2022
2022
BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen
Learn More
Media Coverage
Media Coverage
August 4, 2022
2022
2022
BillionToOne Ranked a Top Healthcare Technology Company of 2022
Learn More
Media Coverage
August 4, 2022
2022
2022
BillionToOne Ranked a Top Healthcare Technology Company of 2022
Learn More
Press Releases
Press Releases
July 8, 2022
2022
2022
BillionToOne launches oncology liquid biopsy products for research use & announces clinical research collaboration with UCSD
Learn More
Press Releases
July 8, 2022
2022
2022
BillionToOne launches oncology liquid biopsy products for research use & announces clinical research collaboration with UCSD
Learn More
Media Coverage
Media Coverage
March 30, 2022
2022
2022
BillionToOne Closes $125M Series C Funding with Premier Global Investors
Learn More
Media Coverage
March 30, 2022
2022
2022
BillionToOne Closes $125M Series C Funding with Premier Global Investors
Learn More
Media Coverage
Media Coverage
February 17, 2022
2022
2022
BillionToOne CEO Oguzhan Atay, PhD, named in Top 25 CEOs in Biotech of 2022 by the Healthcare Technology Report
Learn More
Media Coverage
February 17, 2022
2022
2022
BillionToOne CEO Oguzhan Atay, PhD, named in Top 25 CEOs in Biotech of 2022 by the Healthcare Technology Report
Learn More
Media Coverage
Media Coverage
October 20, 2021
2021
2021
BillionToOne’s Nancy Johnson Named One of the Top 25 Women Leaders in Biotechnology of 2021
Learn More
Media Coverage
October 20, 2021
2021
2021
BillionToOne’s Nancy Johnson Named One of the Top 25 Women Leaders in Biotechnology of 2021
Learn More
1
Social Posts
Follow us
LinkedIn
X
Social Posts